Texcell
Created in 2003
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
4,908Activities
Technologies
Entity types
Location
1 Rue Pierre Fontaine 5, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 51-200
Estimated: 107
SIREN
444906978Engaged corporates
8
1 7Added in Motherbase
3 years, 8 months ago
biotech Value proposition
Expert in viral safety since 1987.
Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades.
Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing.
Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays
What do we provide ?
A specialized analytical lab for your preclinical and clinical studies, including:
- Cell based assays/potency assays during development
- Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing
- Immunotoxicology studies
- Sample pre analytics: serum/plasma isolation, PBMC isolation & storage
- Biobanking
- Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation...
Texcell Viral Safety lab:
Expertise in biosafety of biological and pharmaceutical products.
- Virus/TSE Validation - Viral Clearance study - 25 model viruses available - spiking in L2 and L3 labs...
- Viral safety testing - a complete range of tests (NGS, in vitro, in vivo, TEM, Q-PCR...) to characterize cell banks and ensure microbiological safety (viruses, mycoplasma, etc...).
- Cell and Gene therapy (ATMPs) and Biodistribution/biodissemination - experience with adenovirus, retrovirus, lentivirus...
- Virucidal Norm and cleaning validation
- Standard Toxicology and Medical Device Biocompatibility studies (ISO 10993)
Texcell GMP cell bank facility:
Expertise in handling and growing more than one hundred mammalian cell lines.
- Production of RCB, MCB and WCB in GMP
- Modern class B and class C cell culture room
- Dedicated class B room to fill automatically cells in vials
- Culture of adherent and suspension cell line with single use disposable
- Viral safety control of cell banks performed directly in-house
For more information visit www.texcell.com.
Viral Safety, Bioanalysis, GLP, GMP, GCLP, Medical Device, Biosafety Testing, Viral Clearance, Safety Testing, Immunoprofiling, and Clinical trialsOriginal language
Expert in viral safety since 1987.
Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades.
Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing.
Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays
What do we provide ?
A specialized analytical lab for your preclinical and clinical studies, including:
- Cell based assays/potency assays during development
- Immunogenicity, TK/PK, ADA and neutralizing Antibody Testing
- Immunotoxicology studies
- Sample pre analytics: serum/plasma isolation, PBMC isolation & storage
- Biobanking
- Read-outs: ELISA, ECLIA, Flow cytometry, ELISpot, HAI, proliferation...
Texcell Viral Safety lab:
Expertise in biosafety of biological and pharmaceutical products.
- Virus/TSE Validation - Viral Clearance study - 25 model viruses available - spiking in L2 and L3 labs...
- Viral safety testing - a complete range of tests (NGS, in vitro, in vivo, TEM, Q-PCR...) to characterize cell banks and ensure microbiological safety (viruses, mycoplasma, etc...).
- Cell and Gene therapy (ATMPs) and Biodistribution/biodissemination - experience with adenovirus, retrovirus, lentivirus...
- Virucidal Norm and cleaning validation
- Standard Toxicology and Medical Device Biocompatibility studies (ISO 10993)
Texcell GMP cell bank facility:
Expertise in handling and growing more than one hundred mammalian cell lines.
- Production of RCB, MCB and WCB in GMP
- Modern class B and class C cell culture room
- Dedicated class B room to fill automatically cells in vials
- Culture of adherent and suspension cell line with single use disposable
- Viral safety control of cell banks performed directly in-house
For more information visit www.texcell.com.
Texcell : The leading specialist of therapeutic safety
Partnering with clients to assess virus safety for biopharmaceuticals including medical devices, biologics, and cell and gene therapies.
https://texcell.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 26 Jul 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 22 Mar 2024 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 5 Mar 2024 | | |
 Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Gilead Sciences Pharmaceutical, Biotechnology, Biotechnology Research | Other 5 Mar 2024 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Mar 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Mar 2024 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 30 Nov 2022 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 26 Oct 2022 | | |